Physician

Ari D. Fishman, M.D.

According to 2025 Medicare claims, Ari Fishman, M.D. (NPI: 1407963036) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20817-7847.

Fishman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 847 traditional Medicare patients, billed 195,099 HCPCS/CPT codes, and received $2,794,196 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 834 prescription claims across 142 beneficiaries totaling $5,380,057 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 24 claims. Open Payments data shows 9 records totaling $297. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,201,030 to $2,794,196. Similarly, Part D prescription costs have risen steadily, from $638,066 to $5,380,057. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $1,201,030 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $998,218 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,290,100 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,239,186 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,404,301 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,867,844 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,896,044 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,149,651 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,859,045 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,794,196 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015423105,209$1,201,030
2016397107,865$998,218
2017359134,966$1,290,100
2018454119,993$1,239,186
2019458149,921$1,404,301
2020472185,212$1,867,844
2021646176,839$1,896,044
2022775181,516$2,149,651
2023836226,954$2,859,045
2024847195,099$2,794,196

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7M$5.4M2015 Drug cost: $638,066 (USD; Tot_Drug_Cst)2016 Drug cost: $1,352,818 (USD; Tot_Drug_Cst)2017 Drug cost: $1,522,580 (USD; Tot_Drug_Cst)2018 Drug cost: $1,817,388 (USD; Tot_Drug_Cst)2019 Drug cost: $1,899,805 (USD; Tot_Drug_Cst)2020 Drug cost: $1,443,102 (USD; Tot_Drug_Cst)2021 Drug cost: $1,898,805 (USD; Tot_Drug_Cst)2022 Drug cost: $2,869,429 (USD; Tot_Drug_Cst)2023 Drug cost: $3,030,382 (USD; Tot_Drug_Cst)2024 Drug cost: $5,380,057 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201579426$638,066
201680509$1,352,818
201788498$1,522,580
201875496$1,817,388
201976551$1,899,805
202069492$1,443,102
202173453$1,898,805
202296621$2,869,429
202398630$3,030,382
2024142834$5,380,057

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$10K$21K2015 Medicare payment: $20,835 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $8,863 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,116 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $192 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,139 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $880 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $909 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R34$20,835
2016N/R14$8,863
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R46$5,116
2020N/RN/RN/R
2021N/R11$192
2022N/R33$1,139
2023N/R24$880
2024N/R24$909

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5541,065$74
80053Blood test, comprehensive group of blood chemicals274821$10
83550Iron binding capacity156310$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5061,541$8
83540Iron level156310$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide541,486$1,253,398
BrukinsaZanubrutinib712,130$970,959
LenalidomideLenalidomide391,092$587,751
RevlimidLenalidomide28784$537,314
ImbruvicaIbrutinib17480$270,144

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8530Cyclophosphamide; oral, 25 mgNN/R12$683
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R12$226

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$297Intera Oncology, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ari D. Fishman, M.D.?

Tedicare shows public-source Medicare data for Ari D. Fishman, M.D. (NPI 1407963036), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ari D. Fishman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ari D. Fishman, M.D.?

Ari D. Fishman, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Ari D. Fishman, M.D. have Open Payments data?

Ari D. Fishman, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.